1Lee JY,Pulkkinen L,Liu HS,et al.A glycine-to-arginine substitution in the triple-belical domain of type Ⅶ collagen in a family with dominant dystrophic epidermolysis bullosa pruriginosa[J].J Invest Dermatiol,1997,108(6):947-949
2Christiano AM,Crollick J.Pincus S,et al.Squamous cell carcinoma in a family with dominant dystrophic epidermolysis bullosa:a molecular genetic study[J].Exp Dermatol,1999,8(2):146-152
4Horn H M,Tidman M J.The clinical spectrum of dystrophic epidermolysis bullosa[J].Br J Dermatol,2002,146(2):267-74.
5Greenspan D S,Byers M G,Eddy R L,et al.Localization of the human collagen gene COL7A1 to 3p21.3 by fluorescence in situ hybridization[J].Cytogenet Cell Genet,1993,62(1):35-6.
6Christiano A M,Hoffman G G,Chung-Honet L C,et al.Structural organization of the human type VII collagen gene (COL7A1),composed of more exons than any previously characterized gene[J].Genomics,1994,21(1):169-79.
7Iwata T,Nakano H,Nakano A,et al.Dominant dystrophic epidermolysis bullosa caused by a novel G2037R mutation and by a known G2028R mutation in the type VII collagen gene (COL7A1)[J].J Dermatol,2006,33(8):550-6.
8Nakamura H,Sawamura D,Goto M,et al.The G2028R glycine substitution mutation in COL7A1 leads to marked inter-familiar clinical heterogeneity in dominant dystrophic epidermolysis bullosa[J].J Dermatol Sci,2004,34(3):195-200.
9Zhang X J,Song Y X,Zhang X Q,et al.A new glycine substitution mutation in the COL7A1 gene in a Chinese family with dominant dystrophic epidermolysis bullosa[J].Clin Exp Dermatol,2003,28(4):437-9.
10Mallipeddi R,Bleck O,Mellerio J E,et al.Dilemmas in distinguishing between dominant and recessive forms of dystrophic epidermolysis bullosa[J].Br J Dermatol,2003,149(4):810-8.
